What is LCTX's dilution risk score?

LCTX has a latest available DilutionScore record of 46/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for LCTX, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for LCTX?

DilutionWatch tracks 25 SEC filing types for LCTX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect LCTX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For LCTX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for LCTX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for LCTX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

LCTX Dilution Risk Score: 46/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

67

💰 Cash Runway

25

📊 Float Risk

27

⚠️ Warrant Exposure

50

🔄 Convertible Debt

15

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 33%

💰 Capital Raise model 38%

• Active shelf registration ($100M, 30% of market cap)

• Active ATM program with $37M remaining capacity

🔄 Reverse Split model est. 30%

• 50-day avg $1.46 approaching $1 threshold

📜 Warrant Exercise model 25%

• Significant warrants: 16% of shares outstanding

🔔 Track LCTX — Get forecast alerts →

Market Data

Market Cap$331.57M

Shares Outstanding252.91M

Float187.28M

Cash$50.83M

DebtN/A

Short InterestN/A

Institutional Holdings

QoQ: ↑ 23.2% shares (2026Q1 vs prior)

132 institutional holders · 125.87M shares

#1 BROADWOOD CAPITAL INC 49.56M shares

#2 VANGUARD CAPITAL MANAGEMENT LLC 16.64M shares

#3 Defender Capital, LLC. 6.73M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest29.56M

Days to Cover26.2

% of Float15.8%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30

xbrl XBRL CONVERTIBLE 2017-12-31

EFFECT EFFECT 2026-03-23

4 INSIDER TRANSACTION 2026-03-12

S-3 SHELF 2026-03-11

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual LCTX Dilution Snapshot

Lineage Cell Therapeutics, Inc. (LCTX) has a DilutionScore of 46/100, rated Medium dilution risk. Score date: August 28, 2026.

Stored shelf registration capacity: $100.0M.
Stored ATM program remaining capacity: $37.4M.
Stored outstanding warrants: 39.5M.
Recent SEC activity tracked for LCTX: xbrl on 2026-06-30; EFFECT on 2026-03-23; 4 on 2026-03-12.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.